These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25603950)

  • 21. Tumour necrosis factor alpha -308G/A polymorphism and risk of the four most frequent cancers: a meta-analysis.
    Wang J; Cao C; Luo H; Xiong S; Xu Y; Xiong W
    Int J Immunogenet; 2011 Aug; 38(4):311-20. PubMed ID: 21624061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Association between cytotoxic T lymphocyte protein-4 polymorphisms and non-Hodgkin's lymphoma risk: a meta-analysis].
    Yi B; Pei Y; Wang C; Jiang Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1099-104. PubMed ID: 27412943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased cancer risk associated with the -607C/A polymorphism in interleukin-18 gene promoter: an updated meta-analysis including 12,502 subjects.
    Li X; Ren D; Li Y; Xu J; Liu C; Zhao Y
    J BUON; 2015; 20(3):902-17. PubMed ID: 26214646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CCL5-403, CCR5-59029, and Delta32 polymorphisms and cancer risk: a meta-analysis based on 20,625 subjects.
    Ying H; Wang J; Gao X
    Tumour Biol; 2014 Jun; 35(6):5895-904. PubMed ID: 24687549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphisms of the receptor for advanced glycation end-products and glyoxalase I in patients with renal cancer.
    Chocholatý M; Jáchymová M; Schmidt M; Havlová K; Křepelová A; Zima T; Babjuk M; Kalousová M
    Tumour Biol; 2015 Mar; 36(3):2121-6. PubMed ID: 25407489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphisms of receptor for advanced glycation end products and risk of epithelial ovarian cancer in Chinese patients.
    Zhang S; Hou X; Zi S; Wang Y; Chen L; Kong B
    Cell Physiol Biochem; 2013; 31(4-5):525-31. PubMed ID: 23571222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association analysis of -429T/C and -374T/A polymorphisms of receptor of advanced glycation end products (RAGE) gene in Malaysian with type 2 diabetic retinopathy.
    Ng ZX; Kuppusamy UR; Tajunisah I; Fong KC; Chua KH
    Diabetes Res Clin Pract; 2012 Mar; 95(3):372-7. PubMed ID: 22154374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A systematic review and meta-analysis of the relationship between advanced glycation end products ceceptor (RAGE) gene polymorphisms and the risk of inflammatory bowel disease.
    Febrinasari RP; Indah SP; Bastomy ER; Irving S; Azmiardi A; Pribadi RR; Simadibrata M; Sari Y
    Caspian J Intern Med; 2023; 14(3):412-424. PubMed ID: 37520885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The functional -374T/A polymorphism of the receptor for advanced glycation end products may modulate Crohn's disease.
    Däbritz J; Friedrichs F; Weinhage T; Hampe J; Kucharzik T; Lügering A; Broeckel U; Schreiber S; Spieker T; Stoll M; Foell D
    Am J Physiol Gastrointest Liver Physiol; 2011 May; 300(5):G823-32. PubMed ID: 21311028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The -374A allele of the RAGE gene as a potential protective factor for vascular complications in type 2 diabetes: a meta-analysis.
    Lu W; Feng B
    Tohoku J Exp Med; 2010 Apr; 220(4):291-7. PubMed ID: 20410680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association study of polymorphisms in the receptor for advanced glycation end-products (RAGE) gene with susceptibility and prognosis of heart failure.
    Cohen CR; Diel VB; La Porta VL; Rohde LE; Biolo A; Clausell N; Dos Santos KG
    Gene; 2012 Nov; 510(1):7-13. PubMed ID: 22964273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of cytotoxic T lymphocyte antigen-4 +49A/G polymorphism and cancer risk: An updated meta-analysis.
    Gao X; Zhang S; Qiao X; Yao Y; Wang L; Dong D; Ma X; Wang T
    Cancer Biomark; 2014; 14(4):287-94. PubMed ID: 24934372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations between the Genetic Polymorphisms of Osteopontin Promoter and Susceptibility to Cancer in Chinese Population: A Meta-Analysis.
    Liu Y; Lei H; Zhang J; Wang J; Li K; Dong W
    PLoS One; 2015; 10(8):e0135318. PubMed ID: 26267616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of Advanced Glycation End Products (RAGE)-374T/A and Gly82Ser variants and soluble-RAGE levels to obesity in children.
    Kucukhuseyin O; Ozgen T; Karagedik EH; Cesur Y; Yilmaz Aydogan H; Yaylim I; Ergen HA
    Cell Mol Biol (Noisy-le-grand); 2016 Apr; 62(5):9-14. PubMed ID: 27188863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between three eNOS polymorphisms and cancer risk: a meta-analysis.
    Wu X; Wang ZF; Xu Y; Ren R; Heng BL; Su ZX
    Asian Pac J Cancer Prev; 2014; 15(13):5317-24. PubMed ID: 25040995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular endothelial growth factor polymorphisms and risk of Alzheimer's disease: a meta-analysis.
    He D; Lu W; Chang K; Liu Y; Zhang J; Zeng Z
    Gene; 2013 Apr; 518(2):296-302. PubMed ID: 23370341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Association of -429T>C and -374T>A Polymorphisms in the RAGE Gene with Polycystic Ovary Syndrome.
    Park JH; Li L; Choi JW; Baek KH
    Int J Med Sci; 2016; 13(6):451-6. PubMed ID: 27279795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative assessment of caveolin-1 G14713A polymorphism and cancer susceptibility in the Asian population.
    Tang J; Wang G; Li Q; Song R
    Onco Targets Ther; 2016; 9():1381-7. PubMed ID: 27022292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MDM2 SNP309T>G polymorphism with hepatocellular carcinoma risk: a meta-analysis.
    Liu GY; Jiang DK; Shen SQ; Yu L
    Arch Med Res; 2011 Feb; 42(2):149-55. PubMed ID: 21565629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic evaluation of cancer risk associated with rs2292832 in miR‑149 and rs895819 in miR‑27a: a comprehensive and updated meta‑analysis.
    Feng Y; Duan F; Song C; Zhao X; Dai L; Cui S
    Oncotarget; 2016 Apr; 7(16):22368-84. PubMed ID: 26993779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.